Most publicly traded companies in the US have poison pills. That is fairly standard. There are many legal ways to work around it -- acquirers do it all the time. In any event, your point is moot since an acquisition of this sort would be 'friendly'. I doubt that Apple will ever do a 'hostile' deal. In such friendly deals, target company boards usually rescind the pill.